EMGALITY 120 mg/mL

EMGALITY 120 mg/mL is a subcutaneous injection solution containing galcanezumab-gnlm. This medication is designed to help manage specific types of migraines. Learn more about its uses and effects.

EMGALITY 120 mg/mL is primarily used for the preventive treatment of migraines in adults. It is not intended for acute migraine relief but rather to reduce the frequency of migraine episodes. People often ask, 'What is EMGALITY used for?' and the answer is that it targets the underlying mechanisms of migraines to provide long-term management.

Common effects of EMGALITY 120 mg/mL may include injection site reactions, such as redness or pain. Some users might experience nausea or fatigue. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

EMGALITY 120 mg/mL should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for subcutaneous injections. Individuals with known allergies to any of the components should avoid using this medication.

EMGALITY 120 mg/mL may interact with other medications, including those metabolized by certain liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of this treatment.